This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House
Cubist Pharmaceuticals Inc
CBST : NASDAQ : Health Care
$72.50 | %
Today's Range: 0.00 - 0.00
Avg. Daily Volume: 666,500
10/30/14 - 3:59 PM ET

PEER GROUP: Biotechnology

Ticker Company Name Recent
Net Sales
Net Income
CBST CUBIST PHARMACEUTICALS INC 72.42 5504.86 89.41 1164.53 16.38
INCY INCYTE CORP 54.95 9254.24 n/m 371.57 7.05
PCYC PHARMACYCLICS INC 121.32 9131.76 109.30 435.04 606.45
MDVN MEDIVATION INC 99.40 7632.83 368.15 391.92 79.56
ALNY ALNYLAM PHARMACEUTICALS INC 91.81 7011.07 n/m 35.41 -32.67
UTHR UNITED THERAPEUTICS CORP 128.78 6087.30 25.25 1203.45 18.91
ISIS ISIS PHARMACEUTICALS INC 42.37 4988.43 n/m 151.07 33.77
ICPT INTERCEPT PHARMA INC 229.49 4869.32 n/m 1.66 -4.43
SGEN SEATTLE GENETICS INC 35.60 4394.75 n/m 274.96 12.39
OPK OPKO HEALTH INC 8.36 3588.08 n/m 87.15 4.68
CPHD CEPHEID INC 49.18 3452.83 n/m 451.88 18.77
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

CBST Ind Avg S&P 500
89.41 53.09 18.92

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Top Rated Stocks Top Rated Funds Top Rated ETFs